Peer-Review-Artikel 2024

  • Bischoff P, Reck M, Overbeck T, Christopoulos P, Rittmeyer A, Lüders H, Kollmeier J, Kulhavy J, Kemper M, Reinmuth N, Röper J, Janning M, Sommer L, Aguinarte L, Koch M, Wiesweg M, Wesseler C, Waller CF, Kauffmann-Guerrero D, Stenzinger A, Stephan-Falkenau S, Trautmann M, Lassmann S, Tiemann M, Klauschen F, Sebastian M, Griesinger F, Wolf J, Loges S, Frost N; National Network Genomic Medicine Lung Cancer (nNGM) Collaborator Group. Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer. J Thorac Oncol. 2024 May;19(5):803-817. DOI: https://doi.org/10.1016/j.jtho.2023.12.015.

  • Huber T, Krüerke D, Haeck T, Weber M, Kröz M, Schlemmer M, Simões-Wüst AP. Perceived Changes in Anxiety Symptom Burden During Treatment with Bryophyllum pinnatum: A Prospective, Single-Arm Study, Pharmaceuticals (Basel) 17 (2024) 1423. DOI: https://doi.org/10.3390/ph17111423.

  • Matthes H, Baars EW, Brinkhaus B, Christoph M, Edelhäuser F, Grah C, Grün
    demann C, Keßler C, Martin D, Michalsen A, Rosslenbroich B, Siroka J, Soldner G, Teut M, Vagedes J, Willich SN. (2024) The Earth as a Living Organism: Contribution of Integrative Medicine to the Healing of Our Planet (One Health). Complement Med Res. 2024 Jul 26:1-7.

  • Mehl A, Klaus AK, Reif M, Rodrigues Recchia D, Zerm R, Ostermann T, Brinkhaus B, Kröz M. Validation of the Internal Coherence Scale (ICS) in Healthy Geriatric Individuals and Patients Suffering from Diabetes Mellitus Type 2 and Cancer. Geriatrics (Basel). 2024 May 14;9(3):63. DOI: https://doi.org/10.3390/geriatrics9030063.

  • Saccomanno J, Kilic L, Sgarbossa T, Neumann K, Stanzel F, Holland A, Grah C, Gesierich W, Krist J, Ficker J, et al. (2024) Clinical Improvements after Endoscopic Lung Volume Reduction with Valves in Patients with advanced Emphysema and a 6-Minute-Walk-Test ≤140 m at Baseline. ERJ Open Research 2024 00410-2024. DOI: https://doi.org/10.1183/23120541.00410-2024.

  • Schad F, Thronicke A, Hofheinz RD, Klein R, Grabowski P, Oei SL, Wüstefeld H, Grah C. (2024) PD-1/PD-L1 Blockade Combined with AbnobaViscum® Therapy is Linked to Improved Survival in Advanced or Metastatic NSCLC Patients: a Registry Study in Accordance with the ESMO-Guidance for Reporting Real-World Evidence. Pharmaceuticals 2024, 17(12), 1713. DOI: https://doi.org/10.3390/ph17121713.

  • Schad F, Thronicke A, Hofheinz RD, Matthes H, Grah C. Patients with Advanced or Metastasized NSCLC with Viscum album L. Therapy in addition to PD-1/PD-L1 Blockade, A Real-World Data Study. Cancers (Basel). 2024 Apr 22;16(8):1609. DOI: https://doi.org/10.3390/cancers16081609.

  • Sebastian M, Eberhardt WEE, von der Heyde E, Dörfel S, Wiegand J, Schiefer C, Losem C, Jänicke M, Fleitz A, Zacharias S, Kaiser-Osterhues A, Hipper A, Dietel C, Bleckmann A, Benkelmann R, Boesche M, Grah C, Müller A, Griesinger F, Thomas M; CRISP Registry Group. Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: Real-world data from the German prospective CRISP Registry (AIO-TRK-0315). Int J Cancer. 2024 Jun 1;154(11):1967-1978. DOI: https://doi.org/10.1002/ijc.34868.

  • Sgarbossa T, Borchers P, Saccomanno J, Wüstefeld H, Pappe E, Wülfing U, Klein U, Witzenrath M, Stanzel F, Grah C, et al. (2024) Comparison of efficacy and safety of different types of one-way valves in endoscopic lung volume reduction in patients with severe lung emphysema. Eur. Respir. J.;64 (suppl 68):PA4346.